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Abstract
Aim To describe the direct and indirect costs for people with anxiety and depressive
disorders where guidelines are adhered to and patients’ perceived needs are fully met.
Method Data were derived from the Netherlands Study of Depression and Anxiety. At
baseline, adult patients were interviewed and they completed questionnaires to measure
DSM-IV diagnoses, socio-demographic characteristics and perceived need for care. Actual
care data were also derived from electronic medical records. Criteria for guideline adher-
ence were based on general practice guidelines, issued by the Dutch College of General
Practitioners. Direct and indirect costs were inferred from the Perceived Need for Care
Questionnaire administered at baseline, and the Trimbos and iMTA questionnaire on Costs
associated with Psychiatric illness administered at 1-year follow-up.
Results For 568 patients with a current anxiety or depressive disorder a complete dataset
on health care use and absenteeism was available. Guideline adherence was significantly
associated with increased care use and corresponding costs, while fully met perceived need
was unrelated to costs. Socio-demographic characteristics, severity of symptoms and
guideline adherence all affected the societal costs of patients with fully met perceived needs
compared with patients with perceived unmet needs.
Conclusion It appears that guideline-concordant care for anxiety and depression costs
more than non-concordant care, while care that has fulfilled all of a patient’s needs seems
not to be more expensive than care that has not met all perceived needs. However,
randomized controlled trials should first confirm this conclusion.
Introduction
Anxiety and depressive disorders are among the most disabling
diseases in the world [1] and impose a significant economic burden
as a result of high health care utilization [2,3] and productivity
losses [4–6]. In the Netherlands, the 1-year prevalence rate for
anxiety is about 10% and for depression it is 7% [7]. Most patients
are treated in primary care settings but many do not receive any
form of treatment or are not recognized as having anxiety or
depression [8,9]. Other explanations why many people with
anxiety or depression do not seek or receive help are a lack of
awareness of symptoms, lack of knowledge or trust in the available
services, fear of stigma or the absence of a perceived need for
mental health care [10].
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In the past decades, general medical care has been influenced by
two paradigms: ‘evidence-based medicine’ and ‘patient-centred
medicine’ [11]. Likewise within the field of psychiatry, evidence-
based medicine is playing an important role, as represented in the
evidence-based guidelines for various mental disorders. The struc-
tured implementation of evidence-based clinical guidelines has
been advocated as a method to improve the detection and treatment
of common mental disorders and to reduce variations in health care
[12]. Equally, patient-centred medicine has gained in popularity
since the 1970s when the (psychiatric) patients’ rights movement
was at its peak. Patient-centred care refers to services in which
patients’ subjective needs and preferences are seriously taken into
account [13]. Nowadays, evidence-based clinical guidelines are
widely accepted and used to deliver care that is proven effective and
costs no more than necessary, and patients are viewed as ‘consum-
ers’ playing an active role in their own treatment planning.
As it is known that the public in general can have different views
from health professionals about mental disorders and how these
should be treated [14,15], recommendations as formulated in
evidence-based clinical guidelines for anxiety and depression
might be in contrast with patients’ self-perceived care needs. A
clinical dialogue is therefore needed, and both perceived needs and
guidelines can feed this dialogue. However, up to now, cost analy-
ses of guideline-concordant care for anxiety and depression and
cost analyses of care that is in accordance with patients’ self-
perceived needs have scarcely been performed. Although previous
studies have described the costs (and effects) of treatment forms
that have been shown to be effective [16–18], we could not find
any studies that specifically differentiated between patients whose
subjective needs were met and those who felt their needs were not
met. If, in general medicine, care is being delivered until patients’
self-perceived needs are fully met, costs will likely be higher than
for care that is restricted to those services that are strictly required
from a professional’s perspective. When focusing on the field of
psychiatry, in particular on anxiety and depression, it is less
obvious whether care that fulfils patients’ needs is more or less
expensive than guideline-concordant care.
As health care systems will spend considerable resources over
the coming years on treatment programmes for anxiety and
depressive disorders [19], information about health service use and
total costs with guideline adherence and when patients’ self-
perceived care needs are being met might give clues for adapting
mental health care for these common mental disorders. Therefore,
the aim of this study is to describe health service use, and the
corresponding direct and indirect costs for anxiety and depression
treated in accordance with evidence-based clinical guidelines or
treated in accordance with patients’ own needs. More specifically,
we aim to determine the influence of perceived need for care and
guideline adherence on the societal costs of anxiety and depres-
sion, while taking account of the influence of possible confound-
ers. The data of a large naturalistic sample of primary care patients
will be used to approximate the best available real-life situation.
Methods
Study setting and participants
Data on care delivery and mental health status were collected in
the Netherlands Study of Depression and Anxiety (NESDA, http://
www.nesda.nl). NESDA is a multi-centre study designed to
measure the long-term course and consequences of depressive and
anxiety disorders [20]. Data from the baseline wave (T0) and the
wave 1 year later (T1) were used for the current study.
The NESDA study was approved centrally by the Ethics Review
Board of the VU University Medical Centre and by local review
boards of the participating institutes. After full verbal and written
information about the study, written informed consent was
obtained from all participants.
Patients with an anxiety disorder or depressive disorder were
included in NESDA. Between September 2004 and February 2007
adult patients (aged 18–65 years) were recruited from 67 general
practitioners (GPs). Patients who had attended their GP in the
previous 4 months, irrespective of their reason for consultation,
were sent a screening questionnaire consisting of the Kessler-10
[21] and five additional anxiety questions that have been shown to
improve the detection of depressive and anxiety disorders [22].
Those who returned the screener were more likely to be female
(59.3% vs. 50.0%) and older (44.4 years vs. 39.0 years) compared
with those who did not return it [20]. Screen-positive respondents
were interviewed by telephone with the short form of the Com-
posite Interview Diagnostic Instrument (CIDI). Patients who ful-
filled the CIDI short form criteria for a current (6-month recency)
depressive or anxiety disorder and who met further inclusion cri-
teria (not receiving secondary care treatment; sufficient fluency in
Dutch), were asked to participate in NESDA and were invited for
a baseline assessment, including a full CIDI interview, WHO
version 2.1. A total of 743 patients met the criteria for a current
depressive disorder (Major Depressive Disorder, dysthymia)
and/or anxiety disorder (generalized anxiety disorder, social
phobia, panic disorder, agoraphobia) according to DSM-IV (The
DSM-IV is a manual, published by the American Psychiatric Asso-
ciation, listing the official diagnostic classifications of mental dis-
orders.) criteria [23] (see Fig. 1) [20]. Twenty-two patients refused
to give informed consent to extract data from their electronic
medical record (EMR), and for 153 patients we did not have a
complete dataset on health care use and absenteeism. So ultimately
568 patients were included in the current study.
Cost measures
Costs were measured at T0 and T1 for each individual patient from
a societal perspective. Costs are divided into direct costs (e.g. costs
of GP consultations, visits to a psychiatrist, medication, home
care, etc.) and indirect costs (productivity losses) [24]. Because the
use of medical services by depression patients is 30–50% higher
than for patients without depression [5], all health care costs were
taken into account. At T1, patients completed the Trimbos and
iMTA questionnaire on Costs associated with Psychiatric illness
measuring health care utilization, including number of contacts
and loss of productivity at work in the previous year [25]. The data
extracted from the GP’s EMR included detailed information on
number and type of GP visits or contacts, and prescribed
medication.
Table 1 presents the cost categories used in the economic evalu-
ation and prices used. Costs were based on Dutch standard costs
[26]. Indirect costs caused by production losses were estimated
using the friction cost approach [26], based on the mean income of
the Dutch population according to age and gender. The cost of
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medication use was evaluated using prices of the Royal Dutch
Pharmaceutical Society (KNMP) [27]. All costs were adjusted to
the year 2006 using consumer price indices [28], because the
majority of patients in our sample received care during that year.
Actual GP care: guideline-concordant versus
non-concordant care
Data on the delivery of care given to patients with a current anxiety
and/or depression diagnosis were extracted from GPs’ EMRs. The
EMRs dating from 1 year prior to inclusion in NESDA to 1 year
after inclusion were used to derive the following data: number and
type of contacts, International Classification of Primary Care
codes [29], prescribed medication (type and dose), duration of
prescription and referrals. These data were used to determine
whether patients received guideline-concordant care or not.
In our earlier NESDA study [30], a two-round Delphi technique
was used to develop a set of quality indicators, measuring different
aspects of depression and anxiety care. Using these indicators we
described the extent to which GPs adhered to the evidence-based
clinical depression and anxiety guidelines [30], issued by the
Dutch College of General Practitioners, in the delivery of care for
their depression and anxiety patients [31,32]. Guideline-
concordant care was defined as patients having received Psycho-
logical support, including at least five consultations in the 15
weeks after documentation of the diagnosis, or counselling (only
applicable to depression care), or a prescription for antidepressant
medication (including evaluation after 6 weeks of prescription and
a minimal duration of 5 months, or cessation in the case of no
response to treatment), or a referral to a mental health specialist.
Based on the care they had received, patients with a current anxiety
and/or depressive disorder were divided into two groups: (1)
guideline-concordant care and (2) non-guideline-concordant care.
Perceived need for care: fully met needs
versus unmet needs
The Perceived Need for Care Questionnaire assessed the care need
from the perspective of the patient [33]. This needs assessment
instrument has shown acceptable feasibility, reliability and validity
Figure 1 Recruitment flow of the Nether-
lands Study of Depression and Anxiety
(NESDA) respondents in the primary care
setting. *Current = presence during last 6
months, non-current = presence before last 6
months, subthreshold symptoms defined as
screen positives or having a minor depression
according to the Composite Interview Diag-
nostic Instrument (CIDI) interview. MHO,
mental health organizations.
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for epidemiological and health services research [34] and can
determine whether people had a perceived need for specific health
care services in the past 6 months and whether their needs were
fully met or were unmet. The categories of perceived need, or
possible services were: (1) information about mental illness, its
treatment and available services; (2) medication; (3) counselling or
psychotherapy to talk about possible causes of symptoms and learn
to cope with emotional problems; (4) practical support or help to
sort out housing or money problems or help with domestic tasks;
(5) skills training to improve one’s ability to work, or to use one’s
time in other ways or to increase one’s ability to look after oneself
or one’s home; and (6) referral to a specialist.
Furthermore, the Perceived Need for Care Questionnaire distin-
guishes different levels of perceived need: ‘No need’ (has a mental
health problem but did not perceive that they needed help, and did
not receive help) versus ‘Any need’ (perceived need for some kind
of help). The ‘Any need’ category can be further divided into
‘Unmet need’ (perceived that they needed some type of help, but
did not receive any help), ‘Partially met need’ (received some kind
of help, but not as much as they perceive they needed) and ‘Fully
met need’ (received some type of help, and received as much as
they perceive they needed). The ‘Partially met need’ and ‘Unmet
need’ categories were put together, resulting in three groups, that
is, those with: (1) fully met care needs; (2) unmet care needs; or (3)
no need for care. As more pertinent information is obtained by
comparing people who had unmet care needs with those who had
their needs fully met, the ‘No need’ group was left out of the cost
analyses. Descriptions of the patient characteristics and health
service use of this group will be presented.
Possible confounders
As we found in our earlier studies [35,36] that different patient
characteristics (socio-demographics, severity of symptoms, type
of disorder) were related to both independent variables (perceived
need for care and guideline adherence), these factors were taken
into account in the analyses. The presence of chronic somatic
conditions was also measured because all health care costs were
included in the current study.
Patients’ characteristics such as age, gender, education level and
severity of symptoms were ascertained by questionnaire during the
baseline assessment of NESDA. Somatic co-morbidity was mea-
sured with questions about the presence of and treatment received
for 20 different chronic somatic conditions. Severity of depressive
symptoms was measured by the 30-item Inventory of Depressive
Symptoms self-report (scale 0–84), which has shown highly
acceptable psychometric properties [37,38]. Anxiety symptoms
were assessed with the 21-item Beck Anxiety Inventory (scale
0–63) [39]. Higher scores on both the Beck Anxiety Inventory and
the Inventory of Depressive Symptoms indicate more (severe)
symptoms.
As mentioned earlier, type of anxiety or depressive disorder was
determined by the CIDI interview, according to DSM-IV criteria.
To control for type of disorder, three subgroups were formed
consisting of anxiety disorder only, depressive disorder only, and
co-morbidity of both anxiety and depressive disorder.
Statistical and economic analyses
First, univariate tests (c2 and t-test for independent samples) were
used to compare patients who had received guideline-concordant
care with non-guideline-concordant care. The three patient groups
of those with fully met care needs, unmet care needs and no need
for care were compared using c2-tests for categorical variables
(gender, education level, type of diagnosis, treatment for medical
conditions), and analyses of variance (ANOVA) tests for the inter-
val variables (age, severity scores).
Second, descriptive statistics were used to describe health
service use and absenteeism from work for patients who had
received guideline-concordant care and non-concordant care on
the one hand, and patients who still had unmet care needs and
those whose needs were fully met on the other hand. To check
whether differences were significant, t-tests for independent
samples were used.
Third, descriptive statistics were also used to explore the influ-
ence of guideline adherence and fully met perceived need for care
on direct, indirect and total costs. As health care costs usually have
a right-skewed distribution (large numbers of patients incur lower
costs, few patients incur higher costs), the bootstrap method was
used to correct for this type of bias. To estimate 95% confidence
Table 1 Prices used in the economic evaluation
Cost (€)
Direct health care costs
Primary care costs
General practitioner (per 10 minute consultation) 21.03
General practitioner – home visit (per contact) 42.05
General practitioner – telephone contact (per contact) 10.51
General practitioner – (refill) prescription 10.51
Primary care psychologist, social worker or social
psychiatric nurse (visit of max. 1 hour)*
64.78
Physiotherapist (consultation of max. 30 minutes) 23.68
Medication† –
Complementary medicine (per consultation)‡ 47.12
Secondary care costs
Psychotherapist (consultation of max. 1 hour) 72.53
Psychiatrist (consultation of max. 1 hour) 79.11
Regional organization for community mental health
care (visit of max. 1 hour)
129.08
Medical specialist (per contact)§ 81.19
General hospital admission (per day) 350.80
Academic hospital admission (per day) 495.49
Psychiatric hospital admission (per day) 260.24
Rehabilitation centre (per day) 349.76
Supportive care costs
Home care (per hour) 31.96
Indirect health care costs
Company doctor (consultation of max. 20 minutes) 22.11
Absenteeism paid labour (per day)¶ –
*Mean price of all three professionals.
†Prices are based on the Royal Dutch Pharmaceutical Society (KNMP).
‡Mean price of seven alternative therapy types (acupuncture, chiroprac-
tic, homeopathy, haptonomy, manual therapy, osteopathy, spirituality).
§Mean price of outpatient visit to general hospital and academic hospital.
¶Indirect costs for paid labour were calculated according to the friction
cost approach on the basis of the mean income of the Dutch population
stratified for age and gender.
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intervals (CIs) around the cost differences, bias-corrected acceler-
ated bootstrapping with 2000 replications was used [40].
Finally, linear regression analyses were performed to estimate
the relationship between costs and fully met perceived need for
care (vs. unmet need). Severity of symptoms, type of diagnosis and
socio-demographic characteristics were included in the models to
eliminate the effects of these (possible) confounders. After cor-
recting for socio-demographic characteristics and severity of
symptoms in the first two models, guideline adherence and type of
disorder were added to model 3 and model 4 respectively. To
estimate 95% CIs around unadjusted and adjusted cost differences,
again bias-corrected accelerated bootstrapping with 2000 replica-
tions was used [40]. For every bootstrap sample the regression
coefficient for guideline-concordant care was estimated, and bias-
corrected, accelerated 95% CIs were estimated. Analyses were
performed in STATA 10 and SPSS for windows 17.0.
Results
Guideline adherence
Of the 568 included patients, 216 patients (=38%) received
guideline-concordant care, while 352 patients (=62%) received
non-concordant care. There were no significant differences
between the two groups with regard to age, gender or receiving
treatment for one or more somatic diseases (Table 2). However,
patients who received guideline-concordant care were higher edu-
cated and suffered more often from co-morbidity of both anxiety
and depressive disorders, while they suffered less often from an
anxiety disorder only, compared with patients who received non-
concordant care. Patients who received guideline-concordant care
had on average significantly higher severity scores than the non-
concordant care group.
Perceived need for care
More than half (53.7%) of our patient sample had unmet care
needs and only 116 (20.4%) had their needs fully met. Although
fulfilling CIDI criteria for a current anxiety or depressive disorder,
147 patients (25.9%) reported feeling no need for any form of care
(Table 2). Within the group of patients with fully met care needs,
66 (56.9%) had received guideline-concordant care, compared
with 129 (42.3%) in the unmet need and 21 patients (14.3%) in the
no need groups. Patients with fully met care needs suffered less
often from co-morbidity of both anxiety and depressive disorders
compared with those who had unmet care needs. Patients who felt
no need for care more often had an anxiety disorder only, and less
often both anxiety and depressive disorders. This specific ‘no
need’ group also suffered from significantly less severe symptoms.
Patients who had unmet care needs showed the most severe symp-
toms and nearly half of them (45.9%) had both anxiety and depres-
sive disorders. With regard to receiving treatment for somatic
conditions, there were no significant differences found between
the different ‘need’ groups.
Resource use
Table 3 lists health care utilization and absenteeism from paid
work for patients with guideline-concordant care and non-
concordant care, and patients who still had unmet care needs or
whose needs were fully met. Patients who had received guideline-
concordant care used significantly more primary care services,
except for medication prescriptions and physiotherapist visits,
compared with patients who had not received guideline-
concordant care. With regard to secondary care, this former patient
group also had more consultations with a psychotherapist or
Table 2 Patient characteristics of guideline-concordant care versus non-guideline-concordant care and fully met perceived need (FMN), unmet need
(UMN) and no need for care (NN) at baseline
Guideline adherence
P-value
Perceived need for care
P-valueYes (n = 216) No (n = 352) FMN (n = 116) UMN (n = 305) NN (n = 147)
Guideline adherence, n (%) – – 66 (56.9) 129 (42.3) 21 (14.3) **
Female gender (%) 67.1 72.4 n.s. 80 (69.0) 219 (71.8) 101 (68.7) n.s.
Age in years, mean (SD) 45.6 (11.3) 45.5 (12.3) n.s. 45.2 (12.3) 44.7 (11.7) 47.4 (12.0) n.s.
Education level (%)
Basic 3.7 9.4 * 4.3 8.5 6.8 n.s.
Intermediate 62.5 57.1 57.8 57.7 63.3
High 33.8 33.5 37.9 33.8 29.9
Type of diagnosis (%)
Anxiety disorder only 31.0 51.7 ** 37.9 32.5 72.1 **
Depressive disorder only 20.8 20.7 n.s. 23.3 21.6 17.0 n.s.
Co-morbidity of both depressive and anxiety 48.1 27.6 ** 38.8 45.9 10.9 **
Severity of depression symptoms
(IDS) mean (SD) 29.6 (11.7) 24.4 (10.6) ** 25.7 (11.6) 30.3 (10.4) 18.6 (8.4) **
Severity of anxiety symptoms
(BAI) mean (SD) 16.6 (10.0) 14.1 (9.2) * 16.2 (9.0) 17.0 (10.1) 10.3 (6.9) **
Receiving treatment for any chronic medical
conditions (%)
46.8 42.3 n.s. 46.6 44.3 41.5 n.s.
*P  0.05; **P  0.001.
IDS, Inventory of Depressive Symptoms; BAI, Beck Anxiety Inventory; n.s., not significant.
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psychiatrist. Patients who had received care according to the
guidelines more often received home care and had more contacts
with a company doctor. When focusing on patients who had unmet
and fully met care needs, no significant differences were found in
direct and indirect health care use.
Costs of guideline adherence
Patients who received guideline-concordant care generated on
average significantly higher total societal costs than patients who
received non-concordant care (€3266 compared with €2231)
(Table 4). Of the direct costs, primary care costs were €363 higher
for patients who were treated according the guidelines, compared
with patients treated otherwise or not at all. Patients who had
received guideline-concordant care also had significantly higher
supportive care costs (€238), than patients who did not receive
guideline-concordant care (€30). With regard to the indirect costs,
the guideline-concordant care group had higher company doctor
costs (€19 compared with €8).
Costs of perceived fully met care needs
No significant cost differences were found between patients who
had fully met care needs and patients who had unmet care needs.
In general, lost productivity costs were the greatest contributor to
total costs, followed by primary and secondary care costs.
As can be seen in Tables 4 and 5 (uncorrected model), total mean
costs were €324 higher in the fully met need group with slightly
lower direct costs and higher indirect costs, but these differences
were not significant. When perceived need for care was put into a
regression model with costs as the dependent variable and corrected
for age, gender and education level, the total cost difference
decreased markedly, which indicates that these patient characteris-
tics were actual confounders. When costs were also corrected for
severity of symptoms (model 2), cost differences changed again,
meaning that severity of symptoms also exerted some influence on
costs. In this model, direct costs were practically the same but
indirect costs were €579 higher in the fully met need group com-
pared with the unmet need group. Notwithstanding this seemingly
large difference, it did not reach the level of significance. After
introducing guideline adherence to the third model, total cost
differences between the ‘fully met need’ and ‘unmet need’ groups
changed again by more than 10%. Guideline adherence could
therefore be seen as a confounder as well; however, no significant
interaction was found between self-perceived need and guideline
adherence. When type of disorder was included in the final model,
mean costs and 95% CIs no longer showed much change. Accord-
ingly, patients whose perceived need for care was fully met did not
cost society significantly more or less than patients who still had
unmet care needs, but socio-demographic characteristics, severity
of symptoms and whether or not guideline-concordant care was
received all affected the costs for society.
Table 3 Health care utilization and absenteeism from work during 12 months of follow-up for patients who had received guideline-concordant care
(GCC) and non-guideline-concordant care (NGCC), and patients whose needs were fully met (FMN) and unmet (UMN)









Mean (SD) Mean (SD)
Direct health care use
Primary care
GP (number of regular consultations) 12.3 (12.4)** 5.7 (7.3) 9.3 (9.8) 8.8 (10.8)
GP (number of home visits) 0.2 (1.2)* 0.1 (0.6) 0.2 (1.0) 0.2 (1.0)
GP (number of telephone contacts) 3.7 (5.0)** 1.6 (2.7) 3.0 (4.2) 2.6 (4.3)
GP (number of prescriptions) 2.1 (5.6) 1.5 (4.5) 1.4 (3.6) 2.2 (5.8)
Primary care psychologist, social worker or SPN (number of consultations) 2.6 (5.9)** 0.8 (2.7) 2.0 (4.5) 1.8 (5.0)
Physiotherapist (number of consultations) 6.8 (28.2) 4.6 (13.6) 4.3 (12.1) 6.4 (26.2)
Secondary care
Psychotherapist or psychiatrist (number of consultations) 2.0 (6.5)* 1.0 (4.6) 1.5 (4.7) 1.9 (6.6)
Regional institute for community mental health care (number of visits) 0.8 (2.8) 0.6 (6.3) 0.2 (1.6) 1.0 (7.0)
Medical specialist (number of consultations) 1.4 (3.8) 1.6 (3.5) 1.2 (2.2) 1.6 (4.0)
General or academic hospital admission (number of days) 0.4 (2.9) 0.7 (5.8) 0.3 (1.3) 0.4 (2.7)
Psychiatric hospital admission (number of days) 0.4 (6.1) 0.0 (0.0) 0.03 (0.4) 0.3 (5.2)
Rehabilitation centre (number of days) 0.0 (0.0) 0.2 (3.7) 0.0 (0.0) 0.0 (0.0)
Alternative care
Alternative therapist (number of consultations) 1.1 (3.0) 1.1 (4.9) 0.7 (2.0) 1.2 (4.0)
Supportive care
Home care (number of visits) 3.0 (17.7)* 0.4 (3.7) 3.5 (22.3) 1.0 (6.2)
Indirect health care use
Company doctor (number of consultations) 0.9 (2.1)** 0.4 (1.3) 0.8 (1.9) 0.6 (1.8)
Absenteeism paid labour (number of days) 9.0 (29.5) 6.3 (26.4) 8.4 (21.8) 7.8 (32.3)
*P  0.05; **P  0.001
GP, General practitioner; SPN, social psychiatric nurse.
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Discussion and summary
In this study, we evaluated the costs for society in cases where
guideline-concordant care for anxiety or depression was delivered
in comparison with non-guideline-concordant care on the one
hand, and the costs in cases where patients’ self-perceived needs
were fulfilled or not on the other hand. Patients who were not
treated according to the general practice guidelines used less
health services and therefore incurred lower costs than patients
who were treated according to these guidelines. Total societal costs
of guideline-concordant care for patients were on average €1035
higher per patient than non-guideline-concordant care. No signifi-
cant cost differences were found between patients who had fully
met care needs and patients who had unmet care needs. Although
socio-demographics, severity of symptoms and guideline adher-
ence all seem to exert some influence on cost differences between
patients with fully met needs and unmet needs, costs in cases of
guideline adherence appear to be unrelated to costs where patients’
needs are fully met.
Patients who received guideline-concordant care had higher
severity scores than patients who received non-guideline-
concordant care. This difference in severity of symptoms was also
found between the three ‘need’ groups, that is, patients whose
needs were partially met or unmet suffered from the most severe
symptoms. Apparently, patients with the most severe symptoms of
anxiety or depression have the highest chance of receiving
guideline-concordant care, which was also shown in previous
research [41]. However, patients with unmet care needs (who had
the most severe symptoms) did not receive guideline-concordant
care more often than patients with fully met care needs (42% and
57% respectively). This shows that for many patients who received
enough care for their mental health problem according to their own
perception, evidence-based clinical guidelines are not being fully
adhered to.
One might have expected that non-guideline-concordant care or
unmet need for care would result in higher use of services not
directly related to anxiety or depression. However, this was not
found in our study. Patients who did not receive (sufficient) care
for their mental problem, seen from a professional’s and a
patient’s perspective, did not seem to compensate for this by
higher use of services such as physiotherapy, secondary somatic
care or alternative types of care. The finding that lost productivity
Table 4 Mean (SD) total costs (€) of guideline adherence (GCC vs. NGCC) and perceived need for care (FMN vs. UMN) and differences in mean costs
(95% CIs)* during follow-up of 12 months
Cost category
Guideline adherence Perceived need for care
GCC (n = 216) NGCC (n = 352) D Costs (95% CI) FMN (n = 116) UMN (n = 305) D Costs (95% CI)
Direct costs 1742 (2856) 1252 (4043) 490 (-124; 1013) 1331 (2216) 1478 (2480) -147 (-586; 371)
Primary care costs 684 (868) 321 (442) 363 (264; 531) 484 (475) 530 (813) -47 (-184; 72)
Secondary care costs 649 (2085) 669 (3679) -20 (-562; 402) 416 (901) 656 (2043) -240 (-571; 4)
Medication costs 118 (383) 180 (705) -62 (-178; 13) 117 (336) 159 (464) -41 (-117; 42)
Supportive care costs 238 (1415) 30 (299) 208 (75; 507) 283 (1782) 78 (498) 205 (-2; 871)
Indirect costs 1524 (4603) 979 (3478) 545 (-83; 1371) 1612 (4401) 1141 (3926) 472 (-292; 1547)
Company doctor 19 (47) 8 (29) 11 (4; 19) 17 (43) 14 (41) 3 (-5; 14)
Lost productivity costs 1505 (4583) 971 (3467) 534 (-107; 1311) 1595 (4374) 1127 (3913) 468 (-326; 1476)
Total costs 3266 (5977) 2231 (6193) 1035 (42; 2149) 2943 (4941) 2619 (5159) 324 (-624; 1557)
Figures in bold P  0.05.
*95% CIs obtained by bootstrapping.
GCC, guideline-concordant care; NGCC, non-guideline-concordant care; FMN, fully met need; UMN, unmet need.
Table 5 Linear regression models evaluating the relationship between costs (€) during follow-up of 12 months and perceived need for care (FMN vs.
UMN)
Direct costs Indirect costs Total costs
DC (95% CI)* DC (95% CI)* DC (95% CI)*
Uncorrected model -147 (-562; 448) 472 (-286; 1652) 324 (-667; 1454)
Model 1 -162 (-600; 376) 379 (-438; 1476) 217 (-793; 1452)
Corrected for age, gender, education
Model 2 1 (-412; 513) 579 (-246; 1842) 580 (-421; 1817)
Corrected for age, gender, education, severity of symptoms
Model 3 -112 (-519; 396) 521 (-353; 1633) 410 (-651; 1584)
Corrected for age, gender, education, severity of symptoms, guideline adherence
Model 4 -108 (-529; 367) 504 (-294; 1648) 396 (-661; 1580)
Corrected for age, gender, education, severity of symptoms, guideline adherence,
type of diagnosis
Figures presented are mean costs in cases of fully met need compared with unmet need.
*95% CIs obtained by bootstrapping.
FMN, fully met need; UMN, unmet need.
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costs were relatively high in general has also been found in pre-
vious studies examining (societal) costs of patients with anxiety
and depressive disorders [2,41,42].
The higher costs for guideline-concordant care are in a sense an
artefact, because guideline-concordant care as provided by the GP
per definition requires several GP contacts. Guideline-concordant
care is associated with seven GP contacts more than non-
guideline-concordant care. Some patients without guideline-
concordant care did not even see any professional. As the higher
costs for guideline-concordant care are mainly generated by
primary care costs, one should keep in mind that guideline-
concordant care, when provided by the GP, is defined by a number
of GP contacts at least. Perceived need for care on the other hand,
is less directly related to actual service use or GP contacts. Patients
who had availed of certain services, indicating that this was suffi-
cient, and did not have care needs that were unmet, were labelled
as ‘fully met need’. Consequently, this group of patients received
some form of care, but not necessarily more than the other ‘need’
groups. The ‘unmet need’ and ‘fully met need’ groups were dif-
ferent with respect to their own perception of having received what
they wanted. Patients with perceived fully met care needs seem to
incur as much cost as patients with unmet care needs, which may
imply that patient-centred care is not especially expensive.
However, a randomized controlled trial (RCT) should further test
this as we can not draw such conclusions from the current data
collected within a naturalistic cohort study.
No specific studies could be found for the purpose of comparing
our findings regarding perceived need for care and costs for
society. Most of the studies that investigated costs of several kinds
of extra treatment, besides care as usual for depression or anxiety,
reported higher costs for guideline-concordant care [43–45]. In all
cases these were RCTs. In our case, we are dealing with a natu-
ralistic design with the inherent characteristic that patients who get
extra treatment (guideline-concordant care) or have unmet care
needs, are the patients with a higher symptom level. Although
naturalistic studies should be considered to be complementary to
RCTs as they reflect everyday clinical practice and avoid protocol
treatment bias, only RCTs can test whether evidence-based care or
patient-centred care is more effective or more expensive.
Strengths and limitations
The strengths of this study are the use of a prospective design in
collecting data to assess guideline adherence and service use, and
its independent assessment of psychiatric status. Diagnoses were
established by the widely accepted CIDI interview, and EMR data
provides objective information on the delivery of care that is free
of recall bias. However, a possible limitation is that cost data were
also partly collected by means of questionnaires. People were
asked about their health care utilization over the past 12 months, so
recall bias might have played some part here.
Furthermore, our cost analyses compared patients who
received guideline-concordant care with those who did not
receive this, based on predefined criteria. As our data permit a
limited number of indicators, guideline adherence is only roughly
defined. Besides, the general practice guidelines used for this
study contain rather basic recommendations for anxiety or
depression care, as guidelines are not strict protocols and GPs’
clinical views and knowledge of the specific circumstances
should also guide their decisions. Patients’ perceived need for
care was assessed by a (validated) questionnaire completed by
those who perceived themselves to have a mental problem. Con-
sequently, people with an anxiety or depressive disorder, accord-
ing to DSM-IV criteria, who did not think they were suffering
from a mental health problem, were not asked about their need
for care and are therefore missing from the analyses. In addition,
147 patients who did not feel a need for care and indicated not to
have received any (the no need group) were not included in the
cost analyses, leading to a smaller patient group for the analyses
regarding perceived need (n = 421) than for guideline adherence
(n = 568). Nevertheless, we did not aim to compare these two
groups (perceived need for care and guideline adherence), which
are based on different criteria, as this would have resulted in
overlapping patient groups. We only described the costs of these
groups from different perspectives: evidence-based medicine and
patient-centred medicine, looking for associations and taking
account of the influence of possible confounders.
All health care costs were taken into account as research shows
that people with mental disorders use medical services more often
than people without mental problems. The presence of other
(chronic) medical conditions may have influenced the total costs
per subgroup. However, this influence is limited because patients
did not differ significantly in receiving treatment for any chronic
medical conditions.
Conclusion
Our findings suggest that guideline-concordant care for anxiety
and depression costs more than care that is not guideline-
concordant, while care that has fulfilled all a patient’s needs seems
not to be more expensive than care that has not fulfilled all per-
ceived needs. Apart from the costs, evidence-based care for
anxiety and depression seems to be unrelated to patient-centred
care. If future (RCT) research can confirm our cautiously stated
conclusion that patient-centred care is possibly not more expensive
than care that does not fulfil patients’ needs, one could recommend
(from a cost perspective) the provision of care that fulfils patients
self-perceived needs.
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